The global Spinal Muscular Atrophy (SMA) Market is estimated to be valued at US$ 1,600.6 million in 2023 and is expected to exhibit a CAGR of 13.3% over the forecast period of 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Spinal Muscular Atrophy is a rare genetic disorder characterized by muscle weakness and atrophy, leading to progressive loss of motor ... Read more
